USE OF CICLETANINE AND OTHER FUROPYRIDINES FOR TREATMENT OF SYSTOLIC-PREDOMINANT HYPERTENSION, ISOLATED SYSTOLIC HYPERTENSION, ELEVATED PULSE PRESSURE AND GENERAL HYPERTENSION

摘要

1. A formulation comprising a furopyrldine composition, the composition comprising one or more furopyridine compounds, wiierein the daily dosage of the composition is less than 60 mg of cicletanine bioequivalent, the formulation sufficient for the treatment of any of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension. 2. The formulation of claim 1 wherein the furopyridine composition comprises one or more furopyridine derivatives, the derivatives selected from the group consisting of salts, salts with H2O coordinated bonds, esters, clathrates, and chelates.